-

Humana Elects Brad D. Smith to Board of Directors

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Brad D. Smith, former Executive Chairman, President and CEO of Intuit Inc., has been elected as a member of the Company’s Board of Directors. He currently serves as the President of Marshall University, having assumed the role of leading his Alma Mater in January 2022.

Prior to joining Marshall, Smith was Executive Chairman of Intuit from January 2019 until January 2022, following 11 years as Intuit’s President and CEO from January 2008 to December 2018. During Smith’s tenure, he led Intuit’s transformation from a North American financial software company into a global cloud-based platform company, leading to historic record growth that nearly doubled the company’s revenue and positioned Intuit as a leading company in its industry. Smith continues to serve on the Intuit Board of Directors.

“We are pleased to welcome Brad to the Humana Board. He is a seasoned CEO with proven experience in driving transformation through data-driven decision making, rapid experimentation, and customer focus,” said Humana Chairman of the Board Kurt J. Hilzinger. “Brad’s deep operating experience and ability to innovate across all organizational layers, while also being mission and customer driven, will be vital as Humana continues to grow its core Medicare Advantage business, drive operational efficiencies, and mature and further integrate its healthcare services offerings.”

His election brings the number of Humana directors to 14.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information

Contacts

Lisa Stoner
Investor Relations
Humana Inc.
502-580-2652
lstamper@humana.com

Mark Taylor
Corporate Communications
Humana Inc.
317-753-0345
mtaylor108@humana.com

Humana Inc.

NYSE:HUM

Release Versions

Contacts

Lisa Stoner
Investor Relations
Humana Inc.
502-580-2652
lstamper@humana.com

Mark Taylor
Corporate Communications
Humana Inc.
317-753-0345
mtaylor108@humana.com

More News From Humana Inc.

Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 2Q26 earnings call may be accessed via Humana’s Investor Relations page at h...

Humana Announces Agreement to Divest Minority Interest in Gentiva

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation’s leading provider of end-of-life services, including hospice and palliative care. The agreement values Humana’s minority interest stake at approximately $900 million. Other financial terms were not disclosed. Humana intends to utilize proceeds from the sale for genera...

Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended March 31, 2026 (1Q26) versus the quarter ended March 31, 2025 (1Q25) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 1Q26 (a) 1Q25 (a) Generally Accepted Accounting Principles (GAAP) $1,595   $1,691 Amortization associated with identifiable intangibles 11   15 Pu...
Back to Newsroom